Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edesa Biotech Inc (NQ: EDSA )

2.180 +0.010 (+0.46%)
Streaming Delayed Price Updated: 9:30 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 368
Open 2.180
Bid (Size) 2.180 (1)
Ask (Size) 2.290 (2)
Prev. Close 2.170
Today's Range 2.180 - 2.180
52wk Range 2.050 - 6.460
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024
EDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace

Performance

YTD
-53.42%
-53.42%
1 Month
-35.88%
-35.88%
3 Month
-51.34%
-51.34%
6 Month
-48.78%
-48.78%
1 Year
-30.57%
-30.57%

More News

Read More
BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
Via ACCESSWIRE
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024
Via InvestorPlace
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Investor Conferences
Via ACCESSWIRE
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Barclays Global Healthcare Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Dermatology Meetings
Via ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
Via ACCESSWIRE
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q4 2023
Via InvestorPlace
Edesa Biotech Reports Fiscal Year 2023 Results
Via ACCESSWIRE
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exposures Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
Via ACCESSWIRE
Edesa Biotech to Present at Dermatology Drug Development Summit
Via ACCESSWIRE
Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS Drug
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.